Author:
Vink Stefan R.,Schellens Jan H. M.,van Blitterswijk Wim J.,Verheij Marcel
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Oncology
Reference34 articles.
1. Mollinedo F, Fernandez-Luna JL, Gajate C, Martin-Martin B, Benito A, Martinez-Dalmau R, Modolell M: Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L). Cancer Res 57: 1320–1328, 1997
2. Kotting J, Berger MR, Unger C, Eibl H: Alkylphosphocholines: influence of structural variation on biodistribution at antineoplastically active concentrations. Cancer Chemother Pharmacol 30:105–112, 1992
3. Hilgard P, Stekar J, Voegeli R, Engel J, Schumacher W, Eibl H, Unger C, Berger MR: Characterization of the antitumor activity of hexadecylphosphocholine (D 18506). Eur J Cancer Clin Oncol 24: 1457–1461, 1988
4. Stekar J, Hilgard P, Voegeli R, Maurer HR, Engel J, Kutscher B, Nossner G, Schumacher W: Antineoplastic activity and tolerability of a novel heterocyclic alkylphospholipid, D-20133. Cancer Chemother Pharmacol 32: 437–444, 1993
5. Hilgard P, Kampherm E, Nolan L, Pohl J, Reissmann T: Investigation into the immunological effects of miltefosine, a new anticancer agent under development. J Cancer Res Clin Oncol 117: 403–408, 1991
Cited by
65 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献